The analysis of the outcome and the risk factors of failure in early breast cancer patients after breast conserving therapy

Nowotwory

Volumn 55, Issue 2, 2005, Pages 122-129

  Niwińska, Anna ^a   Gałecki, Jacek ^a   Nagadowska, Monika ^a   Michalski, Wojciech ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Breast cancer; Conservative treatment

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PROGNOSIS; RISK FACTOR; TREATMENT FAILURE;

EID: 20444481723     PISSN: 0029540X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Early Breast Cancer Trialist's Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Eng J Med 1995; 333: 1444-55.
2. Fisher B, Anderson S, Redmond C et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Eng J Med 1995; 333: 1456-61.
3. Jeziorski A, Berner J. Wyniki leczenia oszczȩdzaja̧cego u chorych na raka sutka we wczesnym stopniu zaawansowania. Nowotwory 1993; 43: 11-19.
4. Jeziorski A, Berner J, Wrȩżel B. Wyniki odległe leczenia oszczȩdzaja̧cego u chorych na raka sutka. Pol Przegl Chir 1997; 69: 5, 469.
5. Jodkiewicz Z, Malinowski Z, Skowrońska-Gardas A. Ocena wczesnych wyników leczenia i efektu kosmetycznego u chorych napromienianych po oszczȩdzaja̧cym zabiegu chirurgicznym z powodu raka piersi. Nowotwory 2000; 50, 2, 141-47.
6. Gałecki J, Pieńkowski T, Grudzień-Kowalska M, Dyttus-Cebulok K. Powikłania po oszczȩdzaja̧cym leczeniu chorych na raka piersi w I i II stopniu zaawansowania. Nowotowory 1999; 49: 145-52.
7. Niwińska A, Nagadowska M, Tchórzewska H. Ocena efektu kosmetycznego u chorych na raka piersi po leczeniu oszczȩdzaja̧cym. Nowotwory 1998; 48: 835-46.
8. Niwińska A, Nagadowska M, Tchórzewska H. An analysis of factors affecting the cosmetic effect of breast conserving therapy for early breast cancer. Nowotwory 2000; 50: (suppl. 2), 32-37.
9. Jeziorski A. Psychologiczne aspekty leczenia oszczȩdzaja̧ cego chorych na raka sutka. Nowotwory (Suppl II) 1994; 44, 74-8.
10. Tchórzewska H, Niwińska A, Nagadowska M, Pieńkowski T. To what extend the preservation of the breast after breast conserving therapy (BCT) influences the physical, emotional and sexual well-being? 2nd Psycho-Social Impacts of Breast Cancer, UICC Breast Cancer Meeting, 11-14.06.2000, abstract.
11. Niwińska A, Tchórzewska H, Procner M. Czȩstoś ć wystȩpowania obrzȩku limfatycznego kończyny górnej u chorych na raka piersi po leczeniu oszczȩdzajacym. Nowotwory 2003; 53: (suppl. 1) 50, abstract.
12. Pieńkowski T et al. Rak sutka. In: Zasady rozpoznawania i leczenia nowotworów zalecane przez Centrum Onkologii w Warszawie. (ed.) Kułakowski A, Towpik E. PFESO: Warszawa; 1997: 107-120.
13. Gałecki J, Kukołowicz P, Semaniuk A. Leczenie oszczȩdzaja̧ce we wczesnej postaci raka sutka - radioterapia. Nowotwory 1997; 47: (supl 2), 37-44.
14. Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer. Acta Oncologica Suppl 1999; 13: 9-17.
15. Veronesi U., Salvadori B., Luini A et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1973 patients. Eur J Cancer 1995; 31A.
16. Arriagada R, Le MG, Rochard F et al. for the Institut Gustave-Roussy Breast Cancer Group. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol 1996; 14: 1558-64.
17. Jacobson JA, Danforth DN, Cowan KH et al. Ten year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Eng J Med 1995; 332: 907-11.
18. Van Dongen JA, Bartelink H, Fentiman IS et al. Randomized clinical trial to assess the value of breast conserving therapy in stage I and II breast cancer; EORTC trial 10801. Natl Cancer Inst 1992; 11: 15-8.
19. Blichert-Toft M, Rose C, Andersen JA et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis, Danish Breast Cancer Cooperative Group. Natl Cancer Inst 1992; 11: 19-25.
20. Kini VR, White JR, Horowitz EM et al. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting. Cancer 1998; 82: 127-33.
21. Elkhuizen PHM, Van de Vijver MJ, Hermans J et al. Local recurrence after breast conserving therapy for invasive breast cancer: High incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998; 40: 859-67.
22. Fourquet A, Campana F, Zafrani B et al. Prognostic factors in the conservative management for early breast cancer: A 25-year follow-up at the Institute Curie. Int J Radiat Oncol Biol Phys 1989; 17: 719-25.
23. Kini VR, Vicini FA, Fraizer R et al. Mammographic, pathologic and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 1999; 43: 341-346.
24. Mirza NQ, Vlastos G, Meric F et al. Predictors of locoregional recurrence among patients with early stage breast cancer treated with breast conserving therapy. Ann Surg Oncol 2002; 9: 256-65.
25. Touboul E, Buffat L, Belkacemi Y et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999; 43: 25-38.
26. Rouzier R, Extra JM, Carton M et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 2001; 19: 3828-35.
27. Vicini FA, Kestin L, Huang R et al. Does local recurrence affect the rate of distant metastases and survival in patients with early -stage breast carcinoma treated with breast-conserving therapy? Cancer 2003; 97: 910-9.
28. Meric F, Mirza NQ, Vlastos G et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2001; 97: 926-33.
29. McBain CA, Young EA, Swindell R et al. Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome. Clin Oncol 2003; 15: 25-31.
30. Fredriksson I, Liljegren G, Arnesson LG. Et al. Local recurrence in the breast after conservative surgery - a study of prognosis and prognostic factors in 391 women. Eur J Cancer 2002; 38: 1860-70.
31. Fowble B, Solin LJ, Schultz DJ et al. Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990; 19: 833-42
32. Haffty BG, Fisher D, Bienfield M et al. Prognosis following local recurrence in the conservatively treated breast cancer patients. Int J Radiat Oncol Biol Phys 1991; 21: 293-98.
33. Fowble B, Schultz DJ, Overmoyer B et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994; 30: 23-33.
34. Voogd AC, Nielsen M, Peterse JL et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001, 19: 1688-97.
35. Recht A, Connolly JL, Schmitt SJ et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1987; 14: 3-10.
36. Kurtz JM, Jacquemir J, Amalric R et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990; 591-8.
37. Arriagada R, Le MG, Contesso G et al. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2002; 1404-13.
38. Elkhuizen PH, van Slooten HJ, Clahsen PC et al. High local recurrence risk after breast conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy. A European Organization for Research and Treatment of Breast Cancer Cooperative Group Study. J Clin Oncol 2000; 18: 1075-83.
39. Fodor J, Major T, Polgar C et al. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy. Neoplasma 2000; 47: 181-6.
40. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Eng J Med 2001; 345: 1378-87.
41. Fischer B, Redmond C, Dimitrow NV et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Eng J Med 1989; 320: 473-8.
42. Borger JH. The impact of surgical and pathological findings on radiotherapy of early breast cancer. Radiother Oncol 1991; 22: 230-6.
43. Fischer B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Breast and Bowel Project. Word J Surg 1994; 18: 63-9.
44. Park CC, Mitsuori M, Nixon A et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000; 18: 1668-75.
45. Perez CA, Taylor ME, Halverson K et al. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison. Int J Radiat Oncol Biol Phys 1996; 34: 995-1007.
46. DiBiase SJ, Komarnicky LT, Schwartz GF et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998; 82: 2212-20.
47. Dewar JA, Arriagada R, Benhamou S et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy. Cancer 1995; 76: 2260-65.
48. Holland R, Connolly JL, Gelman R et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8: 113-18.
49. Bartelink H, Borger J, van Dongen J et al. The impact of tumor size and histology on local control after breast conserving therapy. Radiother Oncol 1988; 11: 297-303.
50. Voogd AC, Peterse JL, Crommelin MA et al. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Eur J Cancer 1999; 35: 1828-37.
51. Bouvet M, Ollila DW, Hunt KK et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 1997; 4: 650-4.
52. Sastre-Garau X, Jouve M, Asselain B et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996; 7: 113-120.
53. Fischer BJ, Perera FE, Cooke AL. Et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int J Radiat Oncol Biol Phys 1997; 38: 541-50.
54. Bucholtz TA, Tucker SL, Erwin J et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 2001; 19: 2240-6.
55. Fischer B, Constantino J, Redmond C et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Eng J Med 1989; 320: 479-84.
56. Fredriksson L, Liljegren G, Palm-Sjovall M et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003; 90: 1093-102.
57. Freedman Gm, Hanlon AL., Fowble BL et al. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol 2002; 20: 4015-21.
58. Recht A, Come SE, Henderson IC et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early stage breast cancer. N Engl J Med 1996; 334: 1356-61.
59. Froud PJ, Mates D, Jackson JS et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 2000; 46: 363-72.